Literature DB >> 27387696

Improved glucose metabolism after gastric bypass: evolution of the paradigm.

Dimitri J Pournaras1, Jonas Nygren2, Eva Hagström-Toft3, Peter Arner3, Carel W le Roux4, Anders Thorell2.   

Abstract

BACKGROUND: Glucose metabolism is improved in patients with type 2 diabetes after Roux-en-Y gastric bypass (RYGB).
OBJECTIVES: To quantify the relative contribution of calorie restriction, rerouting of nutrients, and adipose tissue reduction.
SETTING: University Hospital.
METHODS: Fifteen diabetic patients, (47±9 yr, body mass index 41.3±4.2 kg/m2) were randomized to a 2-week very low-calorie diet (VLCD) regimen or normal diet before RYGB. A euglycemic-hyperinsulinemic clamp, indirect calorimetry, and a standard meal test were performed prediet, postdiet (preoperatively), and 2 weeks and 12 months postoperatively. The primary outcome was whole-body insulin sensitivity (M) measured with the clamp 2 weeks postoperatively.
RESULTS: In the VLCD group, after 2 weeks of calorie restriction, M improved (2.9±1.3 to 4.2±1.1 mg/kg/min, P = .005) with no further change at 2 weeks postoperatively. In the normal diet group 2 weeks postoperatively, M was similar to the VLCD group (4.7±1.7 versus 4.2±1.1, P = .61). One year postoperatively, M improved further in both groups. The improvement in insulin-stimulated glucose uptake after VLCD and RYGB was entirely accounted for by nonoxidative glucose disposal (NOGD), whereas weight loss at 1 year postoperatively was associated with an increase in NOGD and glucose oxidation. Postprandial glucose improved after VLCD (P<.05) and even more 2 weeks after RYGB (P<.05) with no further change after 1 year.
CONCLUSION: Improved whole-body insulin sensitivity and postprandial glucose response occur early after RYGB. Low calorie intake and rerouting of nutrients contribute through distinct mechanisms. Weight loss contributes by increasing whole-body insulin sensitivity, including glucose oxidation and NOGD. These data suggest that the combination of different mechanisms is what makes RYGB an effective intervention for type 2 diabetes. Copyright Â
© 2016 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Diabetes mellitus type 2; Gastric bypass; Glucose clamp technique; Insulin resistance; Obesity; Randomized controlled trial

Mesh:

Substances:

Year:  2016        PMID: 27387696     DOI: 10.1016/j.soard.2016.03.020

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  12 in total

1.  Effect of Preoperative Weight Loss and Baseline Comorbidity on Short-Term Complications and Reoperations After Laparoscopic Roux-en-Y Gastric Bypass in 2,067 Patients.

Authors:  Tom Wiggins; Dimitri J Pournaras; Elena Priestman; Alan Osborne; Daniel R Titcomb; Ian Finlay; James Hopkins; Marianne Hollyman; Matthew Mason; Hamish Noble; David Mahon; Richard Welbourn
Journal:  Obes Surg       Date:  2021-03-25       Impact factor: 4.129

2.  The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control.

Authors:  Jonathan D Douros; Jenny Tong; David A D'Alessio
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

3.  Pre-operative aerobic exercise on metabolic health and surgical outcomes in patients receiving bariatric surgery: A pilot trial.

Authors:  Nicole M Gilbertson; Julian M Gaitán; Victoria Osinski; Elizabeth A Rexrode; James C Garmey; J Hunter Mehaffey; Taryn E Hassinger; Sibylle Kranz; Coleen A McNamara; Arthur Weltman; Peter T Hallowell; Steven K Malin
Journal:  PLoS One       Date:  2020-10-02       Impact factor: 3.240

Review 4.  Bariatric Surgery Resistance: Using Preoperative Lifestyle Medicine and/or Pharmacology for Metabolic Responsiveness.

Authors:  Nicole M Gilbertson; Andrew S Paisley; Sibylle Kranz; Arthur Weltman; Jennifer L Kirby; Peter T Hallowell; Steven K Malin
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

5.  Body weight-dependent and independent improvement in lipid metabolism after Roux-en-Y gastric bypass in ApoE*3Leiden.CETP mice.

Authors:  Erika Tarasco; Christina N Boyle; Giovanni Pellegrini; Myrtha Arnold; Regula Steiner; Thorsten Hornemann; Dimitris Nasias; Dimitris Kardassis; Lynda Whiting; Thomas A Lutz
Journal:  Int J Obes (Lond)       Date:  2019-07-03       Impact factor: 5.095

6.  Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus.

Authors:  Ville Wallenius; Eveline Dirinck; Lars Fändriks; Almantas Maleckas; Carel W le Roux; Anders Thorell
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

7.  Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 Diabetes.

Authors:  Jamie A Mullally; Gerardo J Febres; Marc Bessler; Judith Korner
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

8.  Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device.

Authors:  James Casella-Mariolo; Lidia Castagneto-Gissey; Giulia Angelini; Andrea Zoli; Pierluigi Marini; Stefan R Bornstein; Dimitri J Pournaras; Francesco Rubino; Carel W le Roux; Geltrude Mingrone; Giovanni Casella
Journal:  EBioMedicine       Date:  2019-08-07       Impact factor: 8.143

9.  Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity.

Authors:  S Ahlin; C Cefalo; I Bondia-Pons; E Capristo; L Marini; A Gastaldelli; G Mingrone; J J Nolan
Journal:  Br J Surg       Date:  2019-06-19       Impact factor: 6.939

Review 10.  Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery.

Authors:  Belén Pérez-Pevida; Javier Escalada; Alexander D Miras; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.